Table 3 Proportion of subjects with 4 or more days/month with pain (or drug consumption) during the baseline period that had a reduction (Improved) or an increase (Worsened) in pain frequency or drug consumption of 50% or more at the end of follow-up
n (%) | 95% CI | |
|---|---|---|
Headache (subjects with at least 4 days/month with headache, n = 73) | ||
Improved | 31 (42.3) | 30.9–54.6 |
Worsened | 3 (4.11) | 0.9–11.5 |
Neck/shoulder pain (subjects with at least 4 days/month with neck/shoulder pain, n = 69) | ||
Improved | 29 (42.0) | 30.2–54.5 |
Worsened | 7 (10.1) | 4.2–19.8 |
Analgesic drug consumption (subjects with at least 4 days/month with drug consumption, n = 24) | ||
Improved | 14 (58.3) | 36.6–77.9 |
Worsened | 1 (4.17) | 0.1–21.1 |